136 results
Page 2 of 7
8-K
EX-10.1
gv9ib9c0 5o3s7
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
EX-2.2
tyrb1 at3z1lu
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
S-4
0b4w8u
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
avia5hce9l54z
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
h0lwmgtt9mv95
28 Apr 22
Prospectus supplement for primary offering
8:09am
8-K
EX-10.1
550qxyi5 iumv341
13 Aug 21
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
k2rbka
13 Aug 21
Entry into a Material Definitive Agreement
4:33pm